Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasnawati Saleh

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Endocrinology|December 6, 2008
Modulation of osteoclast function in bone by the immune systemJulian M W Quinn, Hasnawati Saleh
Endocrinology|March 3, 2011
Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitroHasnawati Saleh, Damien Eeles, Jason M Hodge, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Reflecting on Indonesia's young academy movementInaya Rakhmani, Arief Anshory Yusuf, Hasnawati Saleh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in miceJulian M W Quinn, Natalie A Sims, Hasnawati Saleh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Bone|October 20, 2006
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitroAkira Nakamura, Chi Ly, Mirijana Cipetić, et al.
The Journal of Biological Chemistry|September 11, 2008
Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivoVicky Kartsogiannis, Natalie A Sims, Julian M W Quinn, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Endocrinology|December 6, 2008
Modulation of osteoclast function in bone by the immune systemJulian M W Quinn, Hasnawati Saleh
Endocrinology|March 3, 2011
Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitroHasnawati Saleh, Damien Eeles, Jason M Hodge, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Reflecting on Indonesia's young academy movementInaya Rakhmani, Arief Anshory Yusuf, Hasnawati Saleh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in miceJulian M W Quinn, Natalie A Sims, Hasnawati Saleh, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Bone|October 20, 2006
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitroAkira Nakamura, Chi Ly, Mirijana Cipetić, et al.
The Journal of Biological Chemistry|September 11, 2008
Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivoVicky Kartsogiannis, Natalie A Sims, Julian M W Quinn, et al.
Pageof 1